Vivo Capital »

Aura Biosciences shares owned by Vivo Capital

Quarter-by-quarter ownership of Aura Biosciences (AURA) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Aura Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aura Biosciences held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aura Biosciences by Vivo Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.3M 1.2M 7.10

More positions owned by Vivo Capital

Trevi Therapeutics Common (TRVI)
Praxis Precision Medicines Common (PRAX)
Erasca Common (ERAS)
Arrivent BioPharma Common (AVBP)
Abivax SA - Sponsored Ads (ABVX)
Tango Therapeutics Common (TNGX)
Corvus Pharmaceuticals Common (CRVS)
Bright Minds Biosciences Common (DRUG)
Sinovac Biotech SHS
Tenax Therapeutics Common (TENX)
Aclaris Therapeutics Common (ACRS)
Dyne Therapeutics Common (DYN)
Dianthus Therapeutics Common (DNTH)
Alto Neuroscience Common (ANRO)
DBV Technologies SA Sponsored Ads (DBVT)

View all positions for Vivo Capital

Top funds holding Aura Biosciences

TCG Crossover Management
Suvretta Capital Management
Frazier Life Sciences Management
Long Focus Capital Management
BlackRock
Adage Capital Partners GP
Caligan Partners
Vanguard Capital Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Medicxi Ventures Management
Nantahala Capital Management
Jupiter Topco
RA Capital Management
Balyasny Asset Management

View all funds holding Aura Biosciences